Biederman J, Faraon SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–48. doi:10.1016/S0140-6736(05)66915-2.
Akutagava-Martins GC, Salatino-Oliveira A, Kieling CC, Rohde LA, Hutz MH. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev Neurother. 2013;13(4):435–45. doi:10.1586/ern.13.30.
Thapar A, Cooper M, Eyre O, Langley K. Practitioner review: what have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 2013;54(1):3–16.
Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention‐deficit hyperactivity disorder. Acta Paediatr. 2007;96(9):1269–74.
Coghill D, Bazian L, Faraon SV, Nigg J, Sonuga-Barke E, Rohde LA. A systematic review of the causes of attention deficit hyperactivity disorder (ADHD): an evidence report. London: Department of Health; 2011.
Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, et al. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry. 2009;66(8):722–7.
Obel C, Olsen J, Henriksen TB, Rodriguez A, Järvelin M-R, Moilanen I, et al. Is maternal smoking during pregnancy a risk factor for hyperkinetic disorder?—findings from a sibling design. Int J Epidemiol. 2010:dyq185.
• Henriksen L, Wu CS, Secher NJ, Obel C, Juhl M. Medical augmentation of labor and the risk of ADHD in offspring: a population-based study. Pediatrics. 2015;135(3):e672–7. A large registry-based study with sufficient statistical power to allow adjustment for multiple potentially confounding variables and the detection of small effects.
• Silva D, Colvin L, Hagemann E, Bower C. Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014;133(1):e14–22. A large high-quality population-based study with sufficient statistical power to allow adjustment for multiple potentially confounding variables and the detection of small effects.
Halmøy A, Klungsøyr K, Skjærven R, Haavik J. Pre- and perinatal risk factors in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;71(5):474–81.
Zhu JL, Olsen J, Liew Z, Li J, Niclasen J, Obel C. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics. 2014;134(2):e382–8.
Harris MN, Voigt RG, Barbaresi WJ, Voge GA, Killian JM, Weaver AL, et al. ADHD and learning disabilities in former late preterm infants: a population-based birth cohort. Pediatrics. 2013;132(3):e630–6.
Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry. 2015;20(6):727–34. doi:10.1038/mp.2014.90.
Getahun D, Rhoads GG, Demissie K, Lu SE, Quinn VP, Fassett MJ, et al. In utero exposure to ischemic-hypoxic conditions and attention-deficit/hyperactivity disorder. Pediatrics. 2013;131(1):e53–61.
Langley K, Heron J, Smith GD, Thapar A. Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am J Epidemiol. 2012;176(3):261–8.
Sundquist J, Sundquist K, Ji J. Autism and attention-deficit/hyperactivity disorder among individuals with a family history of alcohol use disorders. eLife. 2014;3, e02917.
Biederman J, Petty CR, Bhide PG, Woodworth KY, Faraone S. Does exposure to maternal smoking during pregnancy affect the clinical features of ADHD? Results from a controlled study. World J Biol Psychiatry. 2012;13(1):60–4. doi:10.3109/15622975.2011.562243.
Wakschlag LS, Lahey BB, Loeber R, Green SM, Gordon RA, Leventhal BL. Maternal smoking during pregnancy and the risk of conduct disorder in boys. Arch Gen Psychiatry. 1997;54(7):670–6.
•• Skoglund C, Chen Q, D’Onofrio BM, Lichtenstein P, Larsson H. Familial confounding of the association between maternal smoking during pregnancy and ADHD in offspring. J Child Psychol Psychiatry. 2014;55(1):61–8. doi:10.1111/jcpp.12124. A high quality study that suggests that the association between maternal smoking during pregnancy and ADHD in the child are due to unmeasured familial confounding rather than the smoking per se.
Thakur GA, Sengupta SM, Grizenko N, Schmitz N, Pagé V, Joober R. Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. NicotineTob Res. 2013;15(1):149–57. doi:10.1093/ntr/nts102.
Sengupta SM, Fortier MÈ, Thakur GA, Bhat V, Grizenko N, Joober R. Parental psychopathology in families of children with attention‐deficit/hyperactivity disorder and exposed to maternal smoking during pregnancy. J Child Psychol Psychiatry. 2015;56(2):122–9. doi:10.1111/jcpp.12286.
Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev. 2003;75(1):21–33.
Milberger S, Biederman J, Faraone SV, Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol. 1998;27(3):352–8.
Cornelius MD, Ryan CM, Day NL, Goldschmidt L, Willford JA. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J Dev Behav Pediatr. 2001;22(4):217–25.
• Laugesen K, Olsen MS, Andersen ABT, Frøslev T, Sørensen HT. In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ Open. 2013;3(9). A large registry study using a sibling control design demonstrated that when controlling for familial factors, previously demonstrated associations between maternal antidepressant use and ADHD were no longer significant.
Liew Z, Ritz B, Rebordosa C, Lee P-C, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313–20. doi:10.1001/jamapediatrics.2013.4914.
Thompson JM, Waldie KE, Wall CR, Murphy R, Mitchell EA, Group AS. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS ONE. 2014;9(9), e108210. doi:10.1371/journal.pone.0108210.
Flory K, Molina BS, Pelham Jr WE, Gnagy E, Smith B. ADHD and risky sexual behavior. ADHD Rep. 2007;15(3):1–4.
Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005;90 suppl 1:i2–7.
Chang Z, Lichtenstein P, D’Onofrio BM, Almqvist C, Kuja-halkola R, Sjölander A, et al. Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study. Int J Epidemiol. 2014;43(6):1815–24.
Park S, Cho S-C, Kim J-W, Shin M-S, Yoo H-J, Oh SM, et al. Differential perinatal risk factors in children with attention-deficit/hyperactivity disorder by subtype. Psychiatry Res. 2014;219(3):609–16. doi:10.1016/j.psychres.2014.05.036.
Chen Q, Sjölander A, Långström N, Rodriguez A, Serlachius E, D’Onofrio BM, et al. Maternal pre-pregnancy body mass index and offspring attention deficit hyperactivity disorder: a population-based cohort study using a sibling-comparison design. Int J Epidemiol. 2014;43(1):83–90.
Andersen SL, Laurberg P, Wu CS, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014;121(11):1365–74.
Liew Z, Ritz B, Bonefeld-Jørgensen EC, Henriksen TB, Nøhr EA, Bech BH, et al. Perfluorinated chemicals in maternal serum and the risk of autism, attention-deficit/hyperactivity disorder and cerebral palsy in children. Eur J Epidemiol. 2013;28(1):S174.
Hoffman K, Webster TF, Weinberg J, Vieira VM, Weisskopf MG. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in US children 12–15 years of age. Environ Health Perspect. 2010;118(12):1762–7.
Stein CR, Savitz DA. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age. Environmental Hazards and Neurodevelopment: Where Ecology and Well-Being Connect. 2015:265.
Ode A, Källén K, Gustafsson P, Rylander L, Jönsson BAG, Olofsson P et al. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood. PLoS ONE. 2014;9(4).
Ode A, Rylander L, Gustafsson P, Lundh T, Källén K, Olofsson P, et al. Manganese and selenium concentrations in umbilical cord serum and attention deficit hyperactivity disorder in childhood. Environ Res. 2015;137:373–81.
Yoshimasu K, Kiyohara C, Takemura S, Nakai K. A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood. NeuroToxicology. 2014;44:121–31.
Malin AJ, Till C. Exposure to fluoridated water and attention deficit hyperactivity disorder prevalence among children and adolescents in the United States: an ecological association children’s environmental health. Environmental Health: A Global Access Science Source. 2015;14(1).